Literature DB >> 30359076

BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway.

Wenbo Yang1, Zhijun Wu1, Ke Yang1,2, Yanxin Han1, Yanjia Chen1, Weilin Zhao1, Fanyi Huang1, Yao Jin1, Wei Jin1.   

Abstract

Cardiac fibrosis has been known to play an important role in the etiology of heart failure after myocardial infarction (MI). B lymphoma Mo-MLV insertion region 1 homolog (BMI1), a transcriptional repressor, is important for fibrogenesis in the kidneys. However, the effect of BMI1 on ischemia-induced cardiac fibrosis remains unclear. BMI1 was strongly expressed in the infarct region 1 wk post-MI in mice and was detected by Western blot and histological analyses. Lentivirus-mediated overexpression of BMI1 significantly promoted cardiac fibrosis, worsened cardiac function 4 wk after the intervention in vivo, and enhanced the proliferation and migration capabilities of fibroblasts in vitro , whereas downregulation of BMI1 decreased cardiac fibrosis and prevented cardiac dysfunction in mice 4 wk post-MI in vivo. Furthermore, upregulated BMI1 inhibited phosphatase and tensin homolog (PTEN) expression, enhanced phosphatidylinositol 3-kinase (PI3K) expression, and increased the phosphorylation level of Akt and mammalian target of rapamycin (mTOR) in mice 4 wk after lentiviral infection, which was in accordance with the changes seen in their infarcted myocardial tissues. At the same time, the effects of BMI1 on cardiac fibroblasts were reversed in vitro when these cells were exposed to NVP-BEZ235, a dual-kinase (PI3K/mTOR) inhibitor. In conclusion, BMI1 is associated with cardiac fibrosis and dysfunction after MI by regulating cardiac fibroblast proliferation and migration, and these effects could be partially explained by the regulation of the PTEN-PI3K/Akt-mTOR pathway. NEW & NOTEWORTHY Ischemia-induced B lymphoma Mo-MLV insertion region 1 homolog (BMI1) significantly promoted cardiac fibrosis and worsened cardiac function in vivo, whereas downregulation of BMI1 decreased cardiac fibrosis and prevented cardiac dysfunction in myocardial infarcted mice. BMI1 also enhanced proliferation and migration capabilities of fibroblasts in vitro; these effects were reversed by NVP-BEZ235. Effects of BMI1 on cardiac fibrosis could be partially explained by regulation of the phosphatase and tensin homolog-phosphatidylinositol 3-kinase/Akt-mammalian target of rapamycin pathway.

Entities:  

Keywords:  B lymphoma Mo-MLV insertion region 1 homolog; cardiac fibrosis; heart failure; mammalian target of rapamycin; myocardial infarction; phosphatase and tensin homolog; phosphatidylinositol 3-kinase

Mesh:

Substances:

Year:  2018        PMID: 30359076     DOI: 10.1152/ajpheart.00487.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  27 in total

1.  B lymphoma Moloney murine leukemia virus insertion region 1 homolog: the Janus-faced polycomb protein that will break your heart.

Authors:  Cameron G McCarthy; Camilla Ferreira Wenceslau; Bina Joe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-21       Impact factor: 4.733

2.  Unsupervised classification of multi-omics data during cardiac remodeling using deep learning.

Authors:  Neo Christopher Chung; Bilal Mirza; Howard Choi; Jie Wang; Ding Wang; Peipei Ping; Wei Wang
Journal:  Methods       Date:  2019-03-07       Impact factor: 3.608

3.  Transcriptome Sequencing Data Reveal LncRNA-miRNA-mRNA Regulatory Network in Calcified Aortic Valve Disease.

Authors:  Kai Huang; Lujia Wu; Yuan Gao; Qin Li; Hao Wu; Xiaohong Liu; Lin Han
Journal:  Front Cardiovasc Med       Date:  2022-05-26

4.  Transcriptomic and ChIP-seq Integrative Analysis Identifies KDM5A-Target Genes in Cardiac Fibroblasts.

Authors:  Yiyao Jiang; Xu Zhang; Ting Wei; Xianjie Qi; Isah Amir Abba; Nana Zhang; Yao Chen; Ran Wang; Chao Shi
Journal:  Front Cardiovasc Med       Date:  2022-07-01

Review 5.  Modulation of mTOR Signaling in Cardiovascular Disease to Target Acute and Chronic Inflammation.

Authors:  Madlen Kaldirim; Alexander Lang; Susanne Pfeiler; Pia Fiegenbaum; Malte Kelm; Florian Bönner; Norbert Gerdes
Journal:  Front Cardiovasc Med       Date:  2022-06-29

6.  MiR-216a accelerates proliferation and fibrogenesis via targeting PTEN and SMAD7 in human cardiac fibroblasts.

Authors:  Jinsong Tao; Jingyi Wang; Chunyu Li; Weiwei Wang; Hao Yu; Jinhui Liu; Xiangqing Kong; Yan Chen
Journal:  Cardiovasc Diagn Ther       Date:  2019-12

7.  Blockade of β-adrenergic signaling suppresses inflammasome and alleviates cardiac fibrosis.

Authors:  Shipeng Dang; Zhen-Ye Zhang; Ku-Lin Li; Jie Zheng; Ling-Ling Qian; Xiao-Yu Liu; Ying Wu; Chang-Ying Zhang; Xiao-Xi Zhao; Zhi-Ming Yu; Ru-Xing Wang; Tingbo Jiang
Journal:  Ann Transl Med       Date:  2020-02

Review 8.  PTEN as a Therapeutic Target in Pulmonary Hypertension Secondary to Left-heart Failure: Effect of HO-3867 and Supplemental Oxygenation.

Authors:  Yazhini Ravi; Chittoor B Sai-Sudhakar; Periannan Kuppusamy
Journal:  Cell Biochem Biophys       Date:  2021-06-16       Impact factor: 2.194

9.  Yes-Associated Protein (Yap) Is Up-Regulated in Heart Failure and Promotes Cardiac Fibroblast Proliferation.

Authors:  Maryam Sharifi-Sanjani; Mariah Berman; Dmitry Goncharov; Mohammad Alhamaydeh; Theodore Guy Avolio; Jeffrey Baust; Baojun Chang; Ahasanul Kobir; Mark Ross; Claudette St Croix; Seyed Mehdi Nouraie; Charles F McTiernan; Christine S Moravec; Elena Goncharova; Imad Al Ghouleh
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  Integrated analysis of mRNA and microRNA expression profiles reveals differential transcriptome signature in ischaemic and dilated cardiomyopathy induced heart failure.

Authors:  Xiuli Shao; Xiaolin Zhang; Lei Yang; Ruijia Zhang; Rongli Zhu; Rui Feng
Journal:  Epigenetics       Date:  2020-10-04       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.